Cargando…

Loss of Expression of a Novel Chromatin Remodeler SMARCA1 in Soft Tissue Sarcoma

INTRODUCTION: Vital cellular processes such as proliferation and differentiation are regulated by chromatin remodeling complexes. A variety of neoplasms have been discovered to have genomic alterations (GAs) and loss of immunohistochemical (IHC) expression of chromatin remodelers ARID1A (BAF250A), S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patil, Pallavi A, Lombardo, Kara, Sturtevant, Ashlee, Mangray, Shamlal, Yakirevich, Evgeny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513346/ https://www.ncbi.nlm.nih.gov/pubmed/31093468 http://dx.doi.org/10.4172/2157-7099.1000524

Ejemplares similares

Claudin Expression in High Grade Invasive Ductal Carcinoma of the Breast: Correlation with the Molecular Subtype
por: Lu, Shaolei, et al.
Publicado: (2012)

Fatal Streptococcus pneumoniae Sepsis in a Patient With Celiac Disease-Associated Hyposplenism
por: Ouseph, Madhu M., et al.
Publicado: (2016)

Coordinated epigenetic regulation of Engrailed-1 by the chromatin remodelers Smarca1 and Smarca5 mediates cerebellar morphogenesis
por: Alvarez-Saavedra, Matias, et al.
Publicado: (2013)

The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
por: Zeng, Xiangwei, et al.
Publicado: (2023)

Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability
por: Husain, Afzal, et al.
Publicado: (2016)

DNA repair goes hip-hop: SMARCA and CHD chromatin remodellers join the break dance
por: Rother, Magdalena B., et al.
Publicado: (2017)

Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma
por: Bellini, Angela, et al.
Publicado: (2019)

Chromatin Remodeler Smarca5 Is Required for Cancer-Related Processes of Primary Cell Fitness and Immortalization
por: Thakur, Shefali, et al.
Publicado: (2022)

SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility
por: Abedini, Atefeh, et al.
Publicado: (2022)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Pathogenic variants in SMARCA5, a chromatin remodeler, cause a range of syndromic neurodevelopmental features
por: Li, Dong, et al.
Publicado: (2021)

Correction to: SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility
Publicado: (2023)

The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
por: Navickas, Sophie M., et al.
Publicado: (2023)

miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype
por: Tommasi, Stefania, et al.
Publicado: (2016)

The chromatin-remodeling enzyme Smarca5 regulates erythrocyte aggregation via Keap1-Nrf2 signaling
por: Ding, Yanyan, et al.
Publicado: (2021)

Is the case really a SMARCA4‐deficient thoracic sarcoma?
por: Kunimasa, Kei
Publicado: (2020)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

Response to ‘Is the case really a SMARCA4‐deficient thoracic sarcoma?’
por: Takada, Kohichi, et al.
Publicado: (2020)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Acute Myeloid Leukemia Evolving from JAK 2-Positive Primary Myelofibrosis and Concomitant CD5-Negative Mantle Cell Lymphoma: A Case Report and Review of the Literature
por: Treaba, Diana O., et al.
Publicado: (2012)

PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma
por: Li, Zhengtian, et al.
Publicado: (2021)

Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
por: Gao, Jie, et al.
Publicado: (2023)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Soft Tissue Sarcomas of the Kidney
por: Köhle, Olivia, et al.
Publicado: (2015)

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

SMARCA4-deficient uterine sarcoma: A case report and a concise review
por: Kord, Ali, et al.
Publicado: (2020)

Notable Response of SMARCA4-Deficient Undifferentiated Uterine Sarcoma to Palliative Radiation Therapy
por: Kurokawa, Mariko, et al.
Publicado: (2021)

Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): A case report
por: Baa, Annie Kanchan, et al.
Publicado: (2021)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

Delays in Referral of Soft Tissue Sarcomas
por: Johnson, G. D., et al.
Publicado: (2008)

Paediatric bone and soft tissue sarcoma
por: Anderson, J
Publicado: (2007)

Studies of an alveolar soft tissue sarcoma.
por: Udekwu, F. A., et al.
Publicado: (1965)

Management of extremity soft tissue sarcomas
por: Puri, Ajay, et al.
Publicado: (2011)

Application of Proteomics to Soft Tissue Sarcomas
por: Kondo, Tadashi, et al.
Publicado: (2012)

Guidelines for the Management of Soft Tissue Sarcomas
por: Grimer, Robert, et al.
Publicado: (2010)

Pazopanib: Approval for Soft-Tissue Sarcoma
por: Nguyen, Diana T., et al.
Publicado: (2013)

Multidisciplinary Management of Soft Tissue Sarcoma
por: Nystrom, Lukas M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8ip4qd1t2o91j2jeammg40k45t